Aerosolized tacrolimus: A case report in a lung transplant recipient

D. Hayes, J. B. Zwischenberger, Heidi - Mansour

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Long-term outcomes after lung transplantation remain poor mainly to the development of bronchiolitis obliterans syndrome (BOS). Currently, treatment options for BOS are very limited. Strategies to prevent and treat this complication include the use of aerosolized therapy with only cyclosporine used in patients to date. We describe the use of aerosolized tacrolimus in a lung transplant recipient with BOS. The patient demonstrated clinical improvement in functional capacity and oxygenation while receiving tacrolimus by nebulization. Further research is needed to study whether aerosolized tacrolimus is beneficial in lung transplant recipients with BOS.

Original languageEnglish (US)
Pages (from-to)3876-3879
Number of pages4
JournalTransplantation Proceedings
Volume42
Issue number9
DOIs
StatePublished - Nov 2010
Externally publishedYes

Fingerprint

Bronchiolitis Obliterans
Tacrolimus
Lung
Lung Transplantation
Cyclosporine
Transplant Recipients
Therapeutics
Research

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Aerosolized tacrolimus : A case report in a lung transplant recipient. / Hayes, D.; Zwischenberger, J. B.; Mansour, Heidi -.

In: Transplantation Proceedings, Vol. 42, No. 9, 11.2010, p. 3876-3879.

Research output: Contribution to journalArticle

Hayes, D. ; Zwischenberger, J. B. ; Mansour, Heidi -. / Aerosolized tacrolimus : A case report in a lung transplant recipient. In: Transplantation Proceedings. 2010 ; Vol. 42, No. 9. pp. 3876-3879.
@article{751a9da0881c463484f78f7b2a441c1c,
title = "Aerosolized tacrolimus: A case report in a lung transplant recipient",
abstract = "Long-term outcomes after lung transplantation remain poor mainly to the development of bronchiolitis obliterans syndrome (BOS). Currently, treatment options for BOS are very limited. Strategies to prevent and treat this complication include the use of aerosolized therapy with only cyclosporine used in patients to date. We describe the use of aerosolized tacrolimus in a lung transplant recipient with BOS. The patient demonstrated clinical improvement in functional capacity and oxygenation while receiving tacrolimus by nebulization. Further research is needed to study whether aerosolized tacrolimus is beneficial in lung transplant recipients with BOS.",
author = "D. Hayes and Zwischenberger, {J. B.} and Mansour, {Heidi -}",
year = "2010",
month = "11",
doi = "10.1016/j.transproceed.2010.08.029",
language = "English (US)",
volume = "42",
pages = "3876--3879",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "9",

}

TY - JOUR

T1 - Aerosolized tacrolimus

T2 - A case report in a lung transplant recipient

AU - Hayes, D.

AU - Zwischenberger, J. B.

AU - Mansour, Heidi -

PY - 2010/11

Y1 - 2010/11

N2 - Long-term outcomes after lung transplantation remain poor mainly to the development of bronchiolitis obliterans syndrome (BOS). Currently, treatment options for BOS are very limited. Strategies to prevent and treat this complication include the use of aerosolized therapy with only cyclosporine used in patients to date. We describe the use of aerosolized tacrolimus in a lung transplant recipient with BOS. The patient demonstrated clinical improvement in functional capacity and oxygenation while receiving tacrolimus by nebulization. Further research is needed to study whether aerosolized tacrolimus is beneficial in lung transplant recipients with BOS.

AB - Long-term outcomes after lung transplantation remain poor mainly to the development of bronchiolitis obliterans syndrome (BOS). Currently, treatment options for BOS are very limited. Strategies to prevent and treat this complication include the use of aerosolized therapy with only cyclosporine used in patients to date. We describe the use of aerosolized tacrolimus in a lung transplant recipient with BOS. The patient demonstrated clinical improvement in functional capacity and oxygenation while receiving tacrolimus by nebulization. Further research is needed to study whether aerosolized tacrolimus is beneficial in lung transplant recipients with BOS.

UR - http://www.scopus.com/inward/record.url?scp=78649455044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649455044&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2010.08.029

DO - 10.1016/j.transproceed.2010.08.029

M3 - Article

C2 - 21094875

AN - SCOPUS:78649455044

VL - 42

SP - 3876

EP - 3879

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 9

ER -